Synthesis and estrogen receptor affinity of a 4-hydroxytamoxifen-labeled ligand for diagnostic imaging

Bioorganic and Medicinal Chemistry

Volumn 10, Issue 12, 2002, Pages 4075-4082

  Lashley, Matthew R ^a   Niedzinski, Edmund J ^a   Rogers, Jane M ^a   Denison, Michael S ^a   Nantz, Michael H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN PENTETIC ACID; ASPARTIC ACID DERIVATIVE; DIAGNOSTIC AGENT; DIAMINE DERIVATIVE; ESTRADIOL; ESTROGEN RECEPTOR; LIGAND; N,N' DIMETHYLETHYLENEDIAMINE; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; BINDING COMPETITION; BREAST CANCER; DIAGNOSTIC IMAGING; DRUG LABELING; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; DRUG UTILIZATION; HYDROPHILICITY; LOW DRUG DOSE; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; CATTLE; CHELATING AGENTS; DIAGNOSTIC IMAGING; FEMALE; LIGANDS; PENTETIC ACID; RADIOLIGAND ASSAY; RADIOPHARMACEUTICALS; RECEPTORS, ESTROGEN; TAMOXIFEN; UTERUS;

EID: 0036973248     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(02)00329-2     Document Type: Article

References (53)

1. (a) DeGregorio, M. W.; Weibe, V. J. Tamoxifen and Breast Cancer. Yale University Press: New Haven, 1994.
2. (b) Landis, S. H.; Murray, T.; Bolden. S.; Wingo, P. A. Cancer Statistics 1999, CA-A Cancer J. Clin. 1999, 49, 8.
3. Tonetti D.A., Jordan V.C. Molec. Med. Today. 1996;218.
4. Landel C.C., Potthoff S.J., Nardulli A.M., Kushner P.J., Greene G.L. J. Steroid Biochem. Molec. Biol. 63:1997;59.
5. Kuuiper G.G.J.M., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.-A. Endocrinology. 138:1997;863.
6. Approximately 60-80% of all breast cancer patients have elevated levels of ER; see: Traish A.M., Newton A.W., Styperek K., Beazley R., Kavanah M. Diagn. Mol. Pathol. 4:1995;220.
7. Struse K., Audretsch W., Rezai M., Pott G., Bojar H. Breast J. 6:2000;115.
8. (a) Knowlden J.M., Gee J.M., Robertson J.F., Ellis I.O., Nicholson R.I. Int. J. Cancer. 89:2000;209
9. (b) Campbell-Thompson M., Lynch I.J., Bhardwaj B. Cancer Res. 61:2001;632
10. (c) Roger P., Sahla M.E., Makela S., Gustafsson J.A., Baldet P., Rochefort H. Cancer Res. 61:2001;2537.
11. (a) Forbes J.F. Seminars in Oncology. 24(S):1997;S1
12. (b) Tonetti D.A., Jordan V.C. Progress in Clinical and Biological Research. 396:1997;245.
13. Paech K., Webb P., Kuiper G.G.J.M., Nilsson S., Gustafasson J.-A., Kushner P.J., Scanlan T.S. Science. 277:1997;1508.
14. Brown K., Brown J.E., Martin E.A., Smith L.L., White I.N.H. Chem. Res. Toxicol. 11:1998;527.
15. (a) Grese T.A., Cho S., Finley D.R., Godfrey A.G., Jones C.D., Lugar C.W., Martin M.J., Matsumoto K., Pennington L.D., Winter M.A., Adrian M.D., Cole H.W., Magee D.E., Phillips D.L., Rowley E.R., Short L.L., Glasebrook A.L., Bryant H.U. J. Med. Chem. 40:1997;146
16. (b) Gao H., Katzenellenbogen J.A., Garg R., Hansch C. Chem. Rev. 99:1999;723.
17. (a) McCague R., Leclercq G., Legros N., Goodman J., Blackburn G.M., Jarman M., Foster A.B. J. Med. Chem. 32:1989;2527
18. (b) Shelby M.D., Newbold R.R., Tully D.B., Chae K., Davis V.L. Environ. Health Perspect. 104:1996;1296
19. (c) Rogers J.M., Denison M.S. In vitro Mol. Toxicol. 13:2000;67.
20. Parker G.J., Law T.L., Lenoch F.J., Bolger R.E. J. Biomol. Screen. 5:2000;77.
21. (a) Katzenellenbogen J.A., Mathias C.J., Vanbrocklin H.F., Brodack J.W., Welch M.J.T. Nucl. Med. Biol. 20:1993;735
22. (b) Katzenellenbogen J.A. J. Nucl. Med. 36(S):1995;8S.
23. Bloomer W.D., McLaughlin W.H., Weichselbaum R.R., Tonnesen G.L., Hellman S., Seitz D.E., Hanson R.N., Adelstein S.J., Rosner A.L., Burstein N.A., Nove J.J., Little J.B. Int. J. Radiat. Biol. 38:1980;197.
24. Strickland L.A., Ponce Y.Z., Hunter D.H., Zabel P.L., Powe J. E.; Morissey, G.; Driedger, A. A.; Chamberlain, M. J.; Tustanoff, E. R., Drug Design and Delivery. 6:1990;195.
25. Yang D.J., Li C., Kuang L.-R., Price J.E., Buzdar A.U., Tansey W., Cherif A., Gretzer M., Kim E.E., Wallace S. Life Sciences. 55:1994;53.
26. Delpassand E.S., Yang D.J., Wallace S., Cherif A., Quadri S.M., Price J., Joubert A., Inoue T., Podoloff D.A. J. Pharm. Sci. 85:1996;553.
27. Bell R.A., Dickson K.C., Valliant J.F. Can. J. Chem. 77:1999;146.
28. Hunter D.H., Luyt L.G. Bioconjugate Chem. 11:2000;175.
29. Joseph D.R. Vitamins Hormones. 49:1994;197.
30. Porto C.S., Musto N.A., Bardin C.W., Gunsalus G.L. Endocrinology. 130:1992;2931.
31. Caravan P., Ellison J.J., McMurry T.J., Lauffer R.B. Chem. Rev. 99:1999;2293.
32. The use of amino-based spacers to improve hydrophilicity of therapeutic agents has been reported, see: Liu S., Edwards D.S. Bioconjugate Chem. 12:2001;7.
33. Agarwal A.K., Bindal R.D. Steroids. 56:1991;486.
34. MacGregor J.L., Jordan V.C. Pharmacol. Rev. 50:1998;151.
35. Brzozowski A.M., Pike A.C.W., Dauter Z., Hubbard R.E., Bonn T., Engsrtrom O., Ohman L., Greene G.L., Gustafasson J.-A., Carlquist M. Nature. 389:1997;753.
36. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., Greene G.L. Cell. 95:1998;927.
37. Williams M.A., Rappoport H. J. Org. Chem. 58:1993;1151.
38. (a) Amedio J.C. Jr., Bernard P.J., Fountain M., Van Wagenen G. Jr. Synth. Commun. 29:1999;2377
39. (b) Corson D.T., Meares C.F. Bioconjugate Chem. 11:2000;292.
40. Amedio J.C. Jr., Van Wagenen G. Jr., Zavlin G., Gyorkos A., Peterson S.A. Synth. Commun. 20:2000;3755.
41. Li R.-L., Hansch C., Kaufman B. J. Med. Chem. 25:1982;435.
42. Robertson D.W., Katzenellenbogen J.A. J. Org. Chem. 47:1982;2387.
43. Olier-Reuchet C., Aitken D.J., Bucourt R., Husson H.-P. Tetrahedron Lett. 36:1995;8221.
44. Apparently, the initially generated, tertiary carbenium ion is sufficiently stabilized so that interception by the primary alcohol gives cyclic ether i as a 1:1 mixture of diastereomers. Interestingly, treatment of i with s-BuLi in THF (-78°C-rt) results in the formation of 18.
45. 3).
46. Osborne C.K., Coronado E., Allred D.C., Weibe V., DeGregorio M. J. Nat. Cancer Inst. 83:1991;1477.
47. Ashton P.R., Koniger R., Stoddart J.F., Alker D., Harding V.D. J. Org. Chem. 61:1996;903.
48. Hayashi H., Nakanishi K., Brandon C., Marmur J. J. Am. Chem. Soc. 95:1973;8749.
49. De Medeiros E.F., Herbert J.M., Taylor R.J.K. J. Chem. Soc., Perkin Trans. 1. 1991;2725.
50. Meares C.F., McCall M.J., Reardan D.T., Goodwin D.A., Diamanti C.I., McTigue M. J. Anal. Biochem. 142:1984;68.
51. (a) Webb P., Lopez G.N., Greene G.L., Baxter J.D., Kushner P.J. Mol. Endocrinol. 6:1992;157
52. (b) Katzenellenbogen B.S., Kendra K.L., Norman M.J., Berthois Y. Cancer Res. 47:1987;4355.
53. Denison M.S., Vella L.M., Okey A.B. J. Biol. Chem. 261:1986;10189.